CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus
Abame, Melkamu Alemu1,2; He, Yang1; Wu, Song3; Xie, Zhifei3; Zhang, Jian3; Gong, Xudong3; Wu, Chunhui3; Shen, Jingshan1,2
刊名NEUROSCIENCE LETTERS
2021-01-23
卷号744页码:7
关键词Synthetic cannabidiol Depression Serotonin Noradrenaline Nuclear factor kappa B
ISSN号0304-3940
DOI10.1016/j.neulet.2020.135594
通讯作者Wu, Chunhui() ; Shen, Jingshan(shenjingshan@simm.ac.cn)
英文摘要Cannabidiol (CBD) is a non-psychotomimetic compound derived from Cannabis sativa. Preclinical and clinical studies have shown therapeutic potential of CBD in a variety of disorders. Despite several research efforts on CBD, its antidepressant activity has been poorly investigated and the exact mechanism of action remains unclear. Thus, this study aimed to further explore the mechanism of CBD after chronic administration (7 days). First, the dose level of CBD that is enough to produce antidepressant effects after chronic administration was explored. Second, the changes in key proteins and neurotransmitters through such methods as real-time polymerase chain reaction (RT-PCR), western blotting, and high-performance liquid chromatography-electrochemical detection (HPLC-ECD) were critically studied. Furthermore, correlation between behavioral phenotypes with protein and neurotransmitters was established and the possible mechanism was herein postulated. The results showed that only the high dose CBD 100 mg/kg chronic administration induced antidepressant-like effects in mice subjected to forced swim test. Chronic CBD 100 mg/kg administration resulted in significant increases in serotonin (5-HT) and noradrenaline (NA) levels in the hippocampus (HPC). Similarly, the chronic administration of CBD 30 mg/kg and CBD 100 mg/kg significantly decreased nuclear factor kappa B (NF-kappa B) expression in the HPC. Moreover, none of the treatments were observed to induce locomotor effects. Thus, we concluded that chronic administration of CBD (100 mg/kg) induced antidepressant-like effects by increasing 5-HT and NA levels in the HPC. These results shed new light on further discovery of the antidepressant effect of CBD.
资助项目Special Foundation of Chinese Academy of Sciences for strategic pilot technology[XDA12040337] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China[2018ZX09711002] ; Belt and Road master fellowship
WOS关键词INVOLVEMENT ; DEPRESSION
WOS研究方向Neurosciences & Neurology
语种英语
出版者ELSEVIER IRELAND LTD
WOS记录号WOS:000608847300011
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/295949]  
专题中国科学院上海药物研究所
通讯作者Wu, Chunhui; Shen, Jingshan
作者单位1.Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Medial, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
2.Univ Chinese Acad Sci, Sch Pharm, Beijing 100049, Peoples R China
3.Topharman Shanghai Co Ltd, Dept Druggabilty Evaluat, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Abame, Melkamu Alemu,He, Yang,Wu, Song,et al. Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus[J]. NEUROSCIENCE LETTERS,2021,744:7.
APA Abame, Melkamu Alemu.,He, Yang.,Wu, Song.,Xie, Zhifei.,Zhang, Jian.,...&Shen, Jingshan.(2021).Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus.NEUROSCIENCE LETTERS,744,7.
MLA Abame, Melkamu Alemu,et al."Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus".NEUROSCIENCE LETTERS 744(2021):7.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace